Literature DB >> 14758530

Association of IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome.

Sung-Do Kim1, Jae-Man Park, Il-Soo Kim, Kang-Duk Choi, Byung-Cheol Lee, Sang-Ho Lee, Seung-Jae Hong, Sheng-Yu Jin, Hee-Jae Lee, Mee-Suk Hong, Joo-Ho Chung, Tae-Won Lee, Chun-Gyoo Ihm, Byoung-Soo Cho.   

Abstract

We investigated the association between IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms and childhood nephrotic syndrome (NS). We analyzed the genetic polymorphism of IL-1beta, IL-1ra, and TNF-alpha genes in 152 patients with childhood NS and 292 healthy adult controls. The C to T exchange at position -511 of IL-1beta and the G to A at -308 of the TNF-alpha gene were genotyped. Five alleles of the IL-1ra gene were identified and designated as IL1RN*1, IL1RN*2, IL1RN*3, IL1RN*4, and IL1RN*5, according to the variable number of tandem repeats in intron 2. The allele frequencies of IL-1beta1 (-511C), IL-1beta2 (-511T), TNF1 (-308G), and TNF2 (-308A) were 53.0, 47.0, 92.1, and 7.9%, respectively, in the childhood NS group. This was not significantly different from normal controls. In the childhood NS group, the allele frequencies of IL1RN*1, IL1RN*2, IL1RN*3, IL1RN*4, and IL1RN*5 were 90.8, 7.6, 1.6, 0, and 0% [IL1RN*1 odds ratio (OR)=0.296, P=0.0001, IL1RN*2 OR=3.902, P=0.0002]. A high allele frequency of IL1RN*2 and a lower allele frequency of IL1RN*1 were found in childhood NS, although there was no association with IL-1beta and TNF-alpha. A high allele frequency of the IL1RN*2 allele may affect disease susceptibility in childhood NS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14758530     DOI: 10.1007/s00467-003-1403-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?

Authors:  Z H Liu; Z H Cheng; Y S Yu; Z Tang; L S Li
Journal:  Kidney Int       Date:  1997-06       Impact factor: 10.612

2.  Effect of anti-interleukin-1 administration to rats with adriamycin-induced nephrosis.

Authors:  T Bricio; A Molina; F Mampaso
Journal:  APMIS       Date:  1992-05       Impact factor: 3.205

Review 3.  Cytokines and growth factors in renal disease.

Authors:  I L Noronha; Z Niemir; H Stein; R Waldherr
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

4.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat.

Authors:  J K Tarlow; A I Blakemore; A Lennard; R Solari; H N Hughes; A Steinkasserer; G W Duff
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

5.  Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome.

Authors:  K Tenbrock; A Schubert; L Stapenhorst; M J Kemper; J Gellermann; K Timmermann; D E Müller-Wiefel; U Querfeld; B Hoppe; D Michalk
Journal:  Clin Sci (Lond)       Date:  2002-05       Impact factor: 6.124

6.  Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein.

Authors:  D B Carter; M R Deibel; C J Dunn; C S Tomich; A L Laborde; J L Slightom; A E Berger; M J Bienkowski; F F Sun; R N McEwan
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

7.  Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity.

Authors:  C L A Mann; M B Davies; V L Stevenson; S M Leary; M D Boggild; C Ko Ko; P W Jones; A A Fryer; R C Strange; A J Thompson; C P Hawkins
Journal:  J Neuroimmunol       Date:  2002-08       Impact factor: 3.478

8.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 9.  Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases.

Authors:  M Hurme; N Lahdenpohja; S Santtila
Journal:  Ann Med       Date:  1998-10       Impact factor: 4.709

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  5 in total

1.  Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.

Authors:  Hyun Jin Choi; Hee Yeon Cho; Han Ro; So Hee Lee; Kyung Hee Han; Hyunkyung Lee; Hee Gyung Kang; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

2.  Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy.

Authors:  Won Ho Hahn; Byoung Soo Cho; Sung Do Kim; Su Kang Kim; Sungwook Kang
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

3.  Musculin/MyoR is expressed in kidney side population cells and can regulate their function.

Authors:  Keiichi Hishikawa; Takeshi Marumo; Shigeki Miura; Asato Nakanishi; Yumi Matsuzaki; Katsunori Shibata; Tomoko Ichiyanagi; Hiroko Kohike; Takuya Komori; Ichiro Takahashi; Osamu Takase; Naohiko Imai; Masahiro Yoshikawa; Toshihiko Inowa; Matsuhiko Hayashi; Toshio Nakaki; Hiromitsu Nakauchi; Hideyuki Okano; Toshiro Fujita
Journal:  J Cell Biol       Date:  2005-06-20       Impact factor: 10.539

4.  Preliminary Study Regarding the Association between Tumor Necrosis Factor Alpha Gene Polymorphisms and Childhood Idiopathic Nephrotic Syndrome in Romanian Pediatric Patients.

Authors:  Ioana Tieranu; Monica I Dutescu; Constantin Bara; Cristian G Tieranu; Mihaela Balgradean; Olivia M Popa
Journal:  Maedica (Bucur)       Date:  2017-09

Review 5.  Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome.

Authors:  Anne M Schijvens; Rob Ter Heine; Saskia N de Wildt; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2018-03-16       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.